Enteric coated digoxin and therapeutic use thereof
US4147768A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 19, 1978 |
| Grant date | Apr 3, 1979 |
| Priority date | — |
| Expiry date | May 19, 1998 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic and undegraded levels of digoxin in warm-blooded animals are achieved by orally admininstering thereto, a non-toxic pharmaceutical enteric-coated tablet comprising: PA1 (a) A cardiotonic effective amount of digoxin; PA1 (b) a non-toxic pharmaceutically acceptable inert diluent, and PA1 (c) a standard non-toxic pharmaceutically acceptable enteric coating. This composition is extremely useful in the treatment of cardiac insufficiency in warm-blooded animals. When administered to warm-blooded animals (e.g., humans), superior therapeutic and undegraded blood levels of digoxin are observed over that normally observed with conventional solid dosage formulations for oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.